Phibro Animal Health (PAHC) Sets New 52-Week Low at $32.02

Phibro Animal Health Corp (NASDAQ:PAHC) reached a new 52-week low during trading on Thursday . The stock traded as low as $32.02 and last traded at $32.78, with a volume of 3129 shares. The stock had previously closed at $32.99.

Several equities research analysts have recently commented on the company. Zacks Investment Research lowered Phibro Animal Health from a “hold” rating to a “strong sell” rating in a research note on Wednesday, October 24th. BidaskClub lowered Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Tuesday, September 18th. Morgan Stanley increased their price target on Phibro Animal Health from $36.00 to $46.00 and gave the stock an “underweight” rating in a research note on Wednesday, August 29th. Finally, ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Monday, November 12th. Three analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The stock has a consensus rating of “Hold” and an average target price of $43.50.

The company has a quick ratio of 1.82, a current ratio of 3.26 and a debt-to-equity ratio of 1.62. The company has a market capitalization of $1.33 billion, a PE ratio of 18.89, a price-to-earnings-growth ratio of 2.83 and a beta of 0.77.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Tuesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.03). Phibro Animal Health had a net margin of 7.89% and a return on equity of 38.91%. The company had revenue of $200.20 million for the quarter, compared to the consensus estimate of $203.99 million. During the same period last year, the company earned $0.38 EPS. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. Analysts expect that Phibro Animal Health Corp will post 1.72 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 19th. Shareholders of record on Wednesday, November 28th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.46%. The ex-dividend date is Tuesday, November 27th. This is an increase from Phibro Animal Health’s previous quarterly dividend of $0.10. Phibro Animal Health’s dividend payout ratio is 27.59%.

In other Phibro Animal Health news, VP Daniel M. Bendheim sold 2,500 shares of the stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $44.30, for a total transaction of $110,750.00. Following the completion of the transaction, the vice president now owns 2,500 shares of the company’s stock, valued at approximately $110,750. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Dean J. Warras sold 10,000 shares of the stock in a transaction dated Thursday, November 1st. The shares were sold at an average price of $42.84, for a total transaction of $428,400.00. Following the transaction, the insider now directly owns 10,000 shares of the company’s stock, valued at approximately $428,400. The disclosure for this sale can be found here. Insiders have sold a total of 13,020 shares of company stock valued at $562,571 in the last three months. Insiders own 50.29% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in PAHC. Victory Capital Management Inc. lifted its holdings in shares of Phibro Animal Health by 15.9% in the 2nd quarter. Victory Capital Management Inc. now owns 8,095 shares of the company’s stock valued at $373,000 after acquiring an additional 1,108 shares during the last quarter. FMR LLC lifted its holdings in shares of Phibro Animal Health by 0.7% in the 2nd quarter. FMR LLC now owns 171,107 shares of the company’s stock valued at $7,879,000 after acquiring an additional 1,109 shares during the last quarter. Macquarie Group Ltd. lifted its holdings in shares of Phibro Animal Health by 16.3% in the 2nd quarter. Macquarie Group Ltd. now owns 9,998 shares of the company’s stock valued at $460,000 after acquiring an additional 1,400 shares during the last quarter. Meeder Asset Management Inc. lifted its holdings in shares of Phibro Animal Health by 34.9% in the 3rd quarter. Meeder Asset Management Inc. now owns 6,028 shares of the company’s stock valued at $258,000 after acquiring an additional 1,558 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its holdings in shares of Phibro Animal Health by 3.8% in the 3rd quarter. Alliancebernstein L.P. now owns 65,520 shares of the company’s stock valued at $2,811,000 after acquiring an additional 2,400 shares during the last quarter. 49.63% of the stock is owned by institutional investors and hedge funds.

WARNING: This news story was first reported by XNewsPress and is the property of of XNewsPress. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://xnewspress.com/news/2018/12/08/phibro-animal-health-pahc-sets-new-52-week-low-at-32-02.html.

About Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.

Featured Article: How much can an individual set aside as a catch-up contribution?

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply